National Heart, Lung, and Blood Institute; Notice of Meeting, 46894 [2024-11856]
Download as PDF
<![CDATA[
46894
Federal Register / Vol. 89, No. 105 / Thursday, May 30, 2024 / Notices
Disability Accommodations: All IACC
Full Committee Meetings provide
Closed Captioning through the NIH
videocast website. Individuals whose
full participation in the meeting will
require special accommodations (e.g.,
sign language or interpreting services,
etc.) must submit a request to the
Contact Person listed on the notice at
least seven (7) business days prior to the
meeting. Such requests should include
a detailed description of the
accommodation needed and a way for
the IACC to contact the requester if
more information is needed to fill the
request. Special requests should be
made at least seven (7) business days
prior to the meeting; last-minute
requests may be made but may not be
possible to accommodate.
Security: During the check-in process,
attendees will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit. Pre-registration is
recommended. Seats will be on a first
come, first served basis, with expedited
check-in for those who are preregistered. Meeting schedule subject to
change.
More Information: Information about
the IACC is available on the website:
https://www.iacc.hhs.gov.
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–11848 Filed 5–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ddrumheller on DSK120RN23PROD with NOTICES1
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be held as a virtual
meeting and will be open to the public
as indicated below. Individuals who
plan to view the virtual meeting and
need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting.
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: July 23, 2024.
Time: 3:00 p.m. to 5:00 p.m.
VerDate Sep<11>2014
20:03 May 29, 2024
Jkt 262001
Agenda: NHLBI Sickle Cell Disease
Program Updates.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
The event is free and open to the public,
however, registration is required. Please use
this link to register: https://
nih.zoomgov.com/webinar/register/WN_
RZK8GeENQWO9DmGH3bBFnQ.
Contact Person: Julie A. Panepinto, MD,
MSPH, DFO/Executive Secretary SCDAC,
Director, Division of Blood Diseases and
Resources, 6701 Rockledge Drive, Suite 9166,
Bethesda, MD 20892, (301) 435–0080,
NHLBIDBDRGrantResource@nhlbi.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/advisory-and-peerreview-committees/nhlbi-sickle-cell-diseaseadvisory-committee, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–11856 Filed 5–29–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; Stakeholder Measures and
Advocate Forms at the National Cancer
Institute (NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
PO 00000
Notice.
Frm 00042
Fmt 4703
Sfmt 4703
In compliance with the
requirement of the Paperwork
Reduction Act of 1995 to provide
opportunity for public comment on
proposed data collection projects, the
National Institutes of Health, National
Cancer Institute (NCI) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 60 days of the date of this
publication.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
comments in writing, or request more
information on the proposed project,
contact: Amy Williams, Director of the
Office of Advocacy Relations (OAR),
NCI, NIH, 31 Center Drive, Bldg. 31,
Room 10A28, MSC 2580, Bethesda, MD
20892, call non-toll-free number 240–
781–3406, or email your request,
including your address, to
amy.williams@nih.gov. Formal requests
for additional plans and instruments
must be requested in writing.
SUPPLEMENTARY INFORMATION: Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimizes
the burden of the collection of
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title:
Stakeholder Measures and Advocate
Forms at the National Cancer Institute
(NCI), 0925–0774, Expiration Date10/
31/2024, REVISION, National Cancer
Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information
Collection: This is a request for OMB to
approve the revision of the collection
titled, ‘‘Stakeholder Measures and
SUMMARY:
E:\FR\FM\30MYN1.SGM
30MYN1
]]>Agencies
[Federal Register Volume 89, Number 105 (Thursday, May 30, 2024)]
[Notices]
[Page 46894]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11856]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be held as a virtual meeting and will be open to
the public as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: July 23, 2024.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: NHLBI Sickle Cell Disease Program Updates.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
The event is free and open to the public, however, registration
is required. Please use this link to register: https://nih.zoomgov.com/webinar/register/WN_RZK8GeENQWO9DmGH3bBFnQ.
Contact Person: Julie A. Panepinto, MD, MSPH, DFO/Executive
Secretary SCDAC, Director, Division of Blood Diseases and Resources,
6701 Rockledge Drive, Suite 9166, Bethesda, MD 20892, (301) 435-
0080, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nhlbi.nih.gov/advisory-and-peer-review-committees/nhlbi-sickle-cell-disease-advisory-committee, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 23, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-11856 Filed 5-29-24; 8:45 am]
BILLING CODE 4140-01-P
